Meridian Bioscience is an integrated life science company. The Company is engaged in developing, manufacturing, selling, and distributing clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics, and Life Science.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Meridian Bioscience Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Meridian Bioscience Inc. market cap is $1.49B.
What is the 52-week high for Meridian Bioscience Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Meridian Bioscience Inc. 52 week high is $34.38 as of September 09, 2025.
What is the 52-week low for Meridian Bioscience Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Meridian Bioscience Inc. 52 week low is $21.09 as of September 09, 2025.
What is Meridian Bioscience Inc. stock price today?
Meridian Bioscience Inc. stock price today is $33.98.
What was Meridian Bioscience Inc. stock price yesterday?
Meridian Bioscience Inc. stock price yesterday was $33.97.
What is the PE ratio of Meridian Bioscience Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Meridian Bioscience Inc.’s P/E ratio is 35.49.
What is the Price-to-Book ratio of Meridian Bioscience Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Meridian Bioscience Inc. P/B ratio is 4.0375.
What is the 50-day moving average of Meridian Bioscience Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Meridian Bioscience Inc. 50-day moving average is $32.94.